Funding Amount

Funding amount not specified in announcement

Deadline

Deadline not published

Grant Type

Foundation

Overview

Wellcome Leap - The Missed Vital Sign Program Overview

Program Budget: $50 million (total program)

Geographic Scope: Global

Focus Areas:

  • Women's health
  • Heavy menstrual bleeding (HMB) research and treatment
  • Healthcare innovation
  • Biomarker identification
  • Non-hormonal therapeutics
  • Human disease modeling
  • Multi-omics analysis
  • AI-driven computational approaches

Program Description:
Wellcome Leap's $50 million "The Missed Vital Sign" program seeks to transform how menstruation is understood and treated in healthcare. The program aims to address the heavy menstrual bleeding crisis affecting one in three women of reproductive age.

Project Awarded to Wyss Institute:
The Wyss Institute received funding to develop the first human Organ Chip model for heavy menstrual bleeding (HMB).

Project Goals:

  • Create uterus chips lined with human endometrial cells, stroma, and microvasculature
  • Replicate both healthy menstrual physiology and HMB
  • Identify causal factors and early biomarkers of HMB progression
  • Identify potential non-hormonal therapeutics
  • Reduce diagnosis and treatment time from 5 years to 5 months

Key Statistics (HMB Impact):

  • Affects one in three women of reproductive age
  • Every minute in the U.S., a woman requires a blood transfusion due to menstruation
  • Up to 50% of reproductive-aged women globally are iron deficient
  • Women with HMB miss average of 3.6 working weeks annually
  • Costs U.S. economy more than $94 billion annually
  • Women with HMB experience anxiety and depression rates 3x higher than general female population

Wyss Institute Expertise:

  • 5+ years of breakthroughs in women's health research
  • Existing Organ Chip models: vagina, cervix, fallopian tube, intestine, lung
  • NeMoCAD AI tool for drug identification and repurposing
  • Multi-omics analysis capabilities

Related Wyss Initiative:
Women's Health Catalyst at the Wyss - founded to support research and innovation addressing critical gaps in therapeutics, diagnostics, and medical devices for women's healthcare

What Hansjorg Wyss Institute for Biologically Inspired Engineering at Harvard Univ Inc actually gave

Source: IRS Form 990, 2025

Grants in 2025
12
Total given
$9.25M
Median grant
$955K
Range
$86K–$1.69M
  • By dollars: Massachusetts 95%, New York 3%, California 2%. Top recipient cities: Boston, MA; Natick, MA; Cambridge, MA.
  • 0% of grants with a stated purpose were for general or operating support.
  • 8% of recipients were new grantees, not repeat recipients.

Example grants

  • Attivare Therapeutics Inc · Natick, MA

    Nonfed sponsored

    $1.69M

  • Massachusetts Institute of Technology · Cambridge, MA

    Fed/nonfed awards

    $1.38M

  • Children's Hospital Corporation · Boston, MA

    Fed/nonfed sponsored

    $1.17M

  • Dana-Farber Cancer Institute Inc · Boston, MA

    Federal sponsored aw

    $1.1M

  • The Massachusetts General Hospital · Boston, MA

    Fed/nonfed sponsored

    $1.1M

IRS Form 990, 2025. Amounts as reported by the funder. Full 990 history →

Focus Areas & Funding Uses

Fields of Work

  • Science research
  • Women
  • Health disparities

Categories

Browse similar grants by category

Related Grants

Open grants from this funder and similar programs

Your AI grants department

Ready to apply for Wellcome Leap - The Missed Vital Sign Program?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found Wellcome Leap - The Missed Vital Sign Program. Now let's win it.

Start writing